HIGHLIGHTS
- who: Inbar Arman et al. from the Laboratory of Molecular Immunology and Immunotherapy, Faculty of Biology, Institute of have published the research: The Intracellular Proteome as a Source for Novel Targets in CAR-T and T-Cell Engagers-Based Immunotherapy, in the Journal: Cells 2023, 12, 27. of 15/Oct/2022
- how: In this approach combining the advantages of the both humoral and cellular adaptive immune_response antibodies mimicking the 4 of 12 binding of a TCR to pMHC class I complex are used to target abnormal peptides presented on the cell surface of malignant or . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.